机器人辅助步态训练
康复理疗
≈ ¥300-800
(≈ $45-120)
大约30-45分钟
免责声明：本站为医疗服务机构，页面信息部分由AI协助制作。健康相关信息不构成医疗建议。如有任何疑问，请咨询医疗专业人士。详情见免责声明
项目介绍
机器人辅助步态训练在一般公立医院参考费用约¥210-640，三甲医院参考费用约¥300-800，常用于相关诊断评估与就医安排，费用随医院及地区有所差异。
主要用途
Primary purpose is neurorehabilitation to restore ambulatory function and improve gait biomechanics in individuals with neurological or musculoskeletal impairments. Key clinical applications include: post-stroke gait retraining, spinal cord injury locomotor recovery, cerebral palsy mobility enhancement, traumatic brain injury balance and walking reintegration, and Parkinson’s disease gait variability reduction. Used in inpatient/outpatient rehabilitation centers, specialized neurorehabilitation clinics, and research settings to deliver high-dose, repetitive, task-specific, and quantifiable gait practice with objective motion capture and real-time feedback.
正常值范围
Robot-assisted gait training is not a diagnostic laboratory test with numerical 'values' or reference ranges; it is a therapeutic rehabilitation intervention. Therefore, there is no universally defined 'normal range' in terms of quantitative metrics. Clinical progress is assessed qualitatively and quantitatively via secondary outcome measures (e.g., walking speed ≥0.8 m/s, Berg Balance Scale score ≥45/56, 6-Minute Walk Test distance ≥300–400 m, Fugl-Meyer Assessment lower extremity score ≥25/34), which vary by patient population, baseline function, and device used (e.g., Lokomat®, G-EO®, HAL®). No standardized biomarker or numeric threshold defines 'normal' performance during robot-assisted training.
偏低可能原因
1. Severe neuromuscular impairment (e.g., chronic spinal cord injury at T4 or higher, advanced Parkinson’s disease with freezing of gait); 2. Significant cognitive deficits limiting task engagement and motor learning; 3. Orthopedic contraindications (e.g., recent joint replacement, unhealed fractures, severe osteoporosis); 4. Cardiovascular instability (e.g., uncontrolled hypertension, NYHA Class III/IV heart failure); 5. Patient intolerance due to pain, spasticity, or anxiety related to robotic interface or weight-bearing.
偏高可能原因
1. High baseline functional capacity enabling rapid adaptation and increased training intensity (e.g., subacute stroke patients with minimal paresis); 2. Optimal neuroplastic responsiveness (e.g., younger age, shorter time since injury, intact corticospinal tract integrity on DTI); 3. High adherence and motivation leading to greater session frequency/duration and progressive overload; 4. Advanced robotic system capabilities (e.g., real-time adaptive control, high-fidelity biofeedback, integrated exoskeletal assistance) facilitating superior kinematic and kinetic output; 5. Concurrent multimodal therapy (e.g., combined with transcranial magnetic stimulation or intensive physical therapy) amplifying neurorehabilitation effects.